Celadon Pharmaceuticals (CEL) Stock Chart & Stock Price History GBX 16.75 -0.75 (-4.29%) As of 02/21/2025 11:24 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Celadon Pharmaceuticals Stock Price Performance 5 Day Performance-6.94%1 Month Performance-26.05%3 Month Performance+30.25%6 Month Performance-29.27%Year-To-Date Performance+19.64%1 Year Performance-84.77% Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CEL Stock Chart for Saturday, February, 22, 2025 CEL Chart by TradingView Celadon Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025GBX 19GBX 16.75-11.84%GBX 19GBX 1640,260 shs£10.27 million02/20/2025GBX 16.18GBX 19+17.43%GBX 19GBX 16.75208,937 shs£11.65 million02/19/2025GBX 15GBX 16.18+7.87%GBX 19GBX 16451,078 shs£9.92 million02/18/2025GBX 18GBX 15-16.67%GBX 18GBX 1542,724 shs£9.20 million02/17/2025GBX 15GBX 18+20.00%GBX 18GBX 1530,765 shs£11.04 million02/14/2025GBX 17.40GBX 15-13.79%GBX 17GBX 1553,714 shs£9.20 million02/13/2025GBX 19.90GBX 17.40-12.56%GBX 23GBX 15.6091,134 shs£10.67 million02/12/2025GBX 16GBX 19.90+24.38%GBX 23GBX 18.66166,494 shs£13.70 million02/11/2025GBX 20GBX 16-20.00%GBX 20GBX 1679,603 shs£11.02 million02/10/2025GBX 18.32GBX 20+9.17%GBX 20GBX 1814,272 shs£13.77 million Get the Latest News and Ratings for CEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025GBX 18.92GBX 18.32-3.15%GBX 23GBX 18101,468 shs£12.61 million02/06/2025GBX 18.92GBX 18.92GBX 23GBX 18402,658 shs£13.02 million02/05/2025GBX 22GBX 18.92-14.02%GBX 23GBX 18.92471,768 shs£13.02 million02/04/2025GBX 15GBX 22+46.67%GBX 23.11GBX 15192,258 shs£15.15 million02/03/2025GBX 17GBX 15-11.76%GBX 18GBX 15258,590 shs£10.33 million01/31/2025GBX 18.11GBX 17-6.13%GBX 17GBX 13636,745 shs£11.70 million01/30/2025GBX 20.40GBX 18.11-11.23%GBX 18.11GBX 1759,076 shs£12.47 million01/29/2025GBX 20GBX 20.40+2.00%GBX 21GBX 18.11103,526 shs£14.05 million01/28/2025GBX 19GBX 20+5.26%GBX 22GBX 18.5043,465 shs£13.77 million01/27/2025GBX 25GBX 19-24.00%GBX 25GBX 19203,257 shs£13.08 million01/24/2025GBX 22.82GBX 25+9.55%GBX 25GBX 20449,891 shs£17.21 million01/23/2025GBX 22.65GBX 22.82+0.75%GBX 23GBX 20478,044 shs£15.71 million01/22/2025GBX 23GBX 22.65-1.52%GBX 27GBX 20214,711 shs£15.60 million01/21/2025GBX 22.50GBX 23+2.23%GBX 23.50GBX 20311,202 shs£15.84 million Related Companies Cambridge Nutritional Sciences Stock Chart Beacon Energy Stock Chart Curzon Energy Stock Chart Vodafone Group Public Stock Chart BT Group Stock Chart BBGI Global Infrastructure Stock Chart Pacific Horizon Investment Trust Stock Chart Venture Life Group Stock Chart ECO Animal Health Group Stock Chart Shield Therapeutics Stock Chart Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CEL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celadon Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Celadon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CEL Stock Alerts